Global Allergy Diagnostics and Therapeutics Market Projected to Reach $55.4 Billion by 2030

Dublin, March 25, 2024 (GLOBE NEWSWIRE) -- The "Allergy Diagnostics and Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to's offering.

Alluring Growth Prospects in Allergy Diagnostics and Therapeutics

The allergy diagnostics and therapeutics industry is set to witness a notable surge in demand, with projections estimating a value growth to $55.4 billion by 2030, expanding at a CAGR of 6.5% between 2024 and 2030. This growth is primarily fueled by the rising prevalence of allergy disorders among children and the elderly, coupled with enhancements in diagnostic tools and techniques.

Diverse Market Segmentation: Driving Innovation and Utility

Instrumental to this sector's advancement are developments in the food, inhaled, and drug allergen types. A detailed analysis of market segments underscores the dynamic nature of allergy diagnostics, highlighting consumables due to their indispensable role in diagnostics. The report further traverses various segments comprising product types, allergen types, test types, and drug classes, acknowledging the substantial growth expected in the drug allergy segment, informed by an elevated awareness and improved access to treatments.

North America to Maintain Dominance in Allergy Diagnostics and Therapeutics Market

North America is forecasted to maintain its leading position, on account of growing allergy incidences and supportive governmental measures. The trends in this region epitomize the wider market landscape's evolution, showcasing increased market opportunities and customer needs.

Key Industry Players Spearhead Market Innovations

The competitive ecosystem is characterized by companies vying for quality and innovation. These players are focused on broadening their manufacturing capabilities, harnessing robust research and development, and deploying integrative strategies across the value chain. Doing so, they are well-poised to meet the burgeoning market demands, improve their competitive stance, and broaden their consumer reach. Key companies marking their presence in the allergy diagnostics and therapeutics market include stalwarts with a proven track record of quality and advancement in the medical diagnostics realm.

Future Direction and Opportunities for Stakeholders

The industry's trajectory is marked by a spate of growth prospects, nuanced market dynamics, and emerging trends. The availability of new developments, an evolving competitive landscape, and the strategic maneuvers by market players, including mergers and acquisitions, set the stage for a transformative impact within the sector. As the elicitation of customer demands and industry challenges shape market dynamics, stakeholders can anticipate and navigate the changing contours of the allergy diagnostics and therapeutics landscape with strategic agility.

The insight provided by the report into the global allergy diagnostics and therapeutics market forecasts, the industry holds a promising future, characterized by innovation, growth, and strategic expansion. With detailed analysis and predictions, key players and emerging trends form pivotal cornerstones in maintaining systemic health and addressing the growing needs of the global population afflicted by allergies.

A selection of companies mentioned in this report includes

  • R-Biopharm
  • Euroimmun Medizinische Labordiagnostika
  • Dasit
  • Aesku
  • Biomerieux
  • Thermo Fisher Scientific
  • Stallergenes Greer

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.